+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years - 70Years
All Genders
ID06512051

Study of SHR-A2102 and Adebrelimab With or Without Other Cancer Treatments in Adults Aged 18 to 70 With Advanced or Metastatic Non-small Cell Lung Cancer

Led by Shanghai Hengrui Pharmaceutical Co., Ltd. · Updated on 2025-12-23

248

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety, tolerability, and effectiveness of SHR-A2102 combined with Adebrelimab, with or without other antitumor therapies, for advanced or metastatic non-small cell lung cancer. The study also explores the appropriate dosage of SHR-A2102 for this condition. This is a Phase IBII, open-label, multicenter trial sponsored by Shanghai Hengrui Pharmaceutical Co., Ltd. Participants receive one of two treatment combinations SHR-A2102 plus Adebrelimab with either Cisplatin or Carboplatin, or SHR-A2102 plus Adebrelimab with Bevacizumab. These drug combinations are given to evaluate their effects and safety in patients with advanced or metastatic non-small cell lung cancer who cannot undergo surgery or radical radiotherapy or chemotherapy. During the study, participants will be closely monitored through various assessments including tumor imaging to measure response, recording any side effects, and evaluating survival outcomes. Primary measures include determining the recommended dose of SHR-A2102, adverse event rates up to 90 days after the last dose, and objective response rates within 18 months after enrollment. Secondary outcomes like disease control, duration of response, progression-free survival, and overall survival are also tracked. The study aims to provide comprehensive safety and efficacy data over an extended follow-up period.

CONDITIONS

Brief Title

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer

Research Team

Y

Yunfei Zhang

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here